Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Somatix acquires exclusive license to gene transfer technology

July 26, 1996

Guilford obtains rights to chemotherapy drug delivery system

July 26, 1996

Ribozyme/Alza research collaboration

July 26, 1996

Techniclone International issued European patent for its Modified Antibodies Technology

July 26, 1996

Isis and ProtoGene renew drug discovery collaboration

July 26, 1996

Millennium and Wyeth-Ayerst collaborate on CNS drugs and gene therapies

July 26, 1996

Biogen and Ontogeny sign CNS drug development collaboration

July 26, 1996

Ontogen and Kanebo enter drug development collaboration

July 26, 1996

University of Michigan issued U.S. patent for gene transfer technology

July 19, 1996

CytoTherapeutics announces new biotech company

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...